Author:
Goebels N.,Wiendl H.,Hohlfeld R.
Publisher
Springer Berlin Heidelberg
Reference82 articles.
1. Aggarwal BB, Natarjan K (1996) Tumor necrosis factor: Developments during the last decade. Eur Cytokine Netw 7:93–124
2. Andersen O, Lycke J, Tollesson PO et al. (1996) Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis. Neurology 47:895–900
3. Bazzoni F, Beutler B (1996) The tumor receptor factor ligand and receptor families. N Engl J Med 334:1717–1725
4. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand 78:318–323
5. Besser M, Wank R (1999) Clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Thl/Th2 polarized expression of their receptors. J Immunol 162:6303–6306